IMPLICATIONS OF FINDINGS IN THE CORONARY DRUG PROJECT FOR SECONDARY PREVENTION TRIALS IN CORONARY HEART-DISEASE

被引：17
作者：
CANNER, PL
机构：
来源：
CIRCULATION | 1981年 / 63卷 / 06期
关键词：
D O I：
10.1161/01.CIR.63.6.1342
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1342 / 1350
页数：9
相关论文
共 33 条
[1]  
[Anonymous], 1971, Br Med J, V4, P767
[2]  
[Anonymous], 1972, JAMA, V220, P996
[3]  
[Anonymous], 1975, JAMA, V231, P360
[4]  
BUCHWALD H, 1974, CIRCULATION S1, V49, P1
[5]  
CORNFIELD J, 1962, FED PROC, V21, P58
[6]   SECONDARY PREVENTION TRIALS USING CLOFIBRATE - JOINT COMMENTARY ON NEWCASTLE AND SCOTTISH TRIALS [J].
DEWAR, HA ;
OLIVER, MF .
BRITISH MEDICAL JOURNAL, 1971, 4 (5790) :784-&
[7]   MORTALITY IN RELATION TO SMOKING - 20 YEARS OBSERVATIONS ON MALE BRITISH DOCTORS [J].
DOLL, R ;
PETO, R .
BRITISH MEDICAL JOURNAL, 1976, 2 (6051) :1525-1536
[8]  
FLEISS JL, 1973, STATISTICAL METHODS
[9]   SAMPLE SIZES FOR MEDICAL TRIALS WITH SPECIAL REFERENCE TO LONG-TERM THERAPY [J].
HALPERIN, M ;
ROGOT, E ;
GURIAN, J ;
EDERER, F .
JOURNAL OF CHRONIC DISEASES, 1968, 21 (01) :13-&
[10]  
LEREN P, 1966, ACTA MED SCAND S466, P1
1234